WASHINGTON, DC
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)NATIONAL BREAST CANCER COALITION FUND, founded in 1991, is a community nonprofit in the Housing & Shelter sector that reported $4.4M in total revenue in fiscal year 2023. Expenses of $4.1M left a modest 8% surplus.
NBCC'S MISSION IS "TO END BREAST CANCER THROUGH THE POWER OF ACTION AND ADVOCACY." NBCC IS MADE UP OF ACTIVISTS WHO SET A PROGRAMMATIC AND RESEARCH AGENDA TO END BREAST CANCER AND USE THE POWER OF ACTION AND ADVOCACY TO FIGHT THE BREAST CANCER STATUS QUO, OVERCOME BARRIERS TO TRUE PROGRESS IN SAVING LIVES, AND EMPOWER AND TRAIN SURVIVORS AND ADVOCATES TO BE LEADERS FOR THIS CAUSE.
EDUCATION AND TRAINING - THE CENTER FOR NBCC ADVOCACY TRAINING SUPPLIES THE EDUCATION, TOOLS, TRAINING, AND ACTION THAT ENABLE BREAST CANCER SURVIVORS AND OTHER ADVOCATES TO UNDERSTAND COMPLEX...
EDUCATION AND TRAINING - THE CENTER FOR NBCC ADVOCACY TRAINING SUPPLIES THE EDUCATION, TOOLS, TRAINING, AND ACTION THAT ENABLE BREAST CANCER SURVIVORS AND OTHER ADVOCATES TO UNDERSTAND COMPLEX MEDICAL AND SCIENTIFIC INFORMATION AND TO TAKE LEADERSHIP ROLES IN CLINICAL, SCIENTIFIC, FUNDING, AND POLICY DECISION-MAKING THAT AFFECT BREAST CANCER.THE ADVOCATE LEADERSHIP SUMMIT IS A THREE-DAY EDUCATIONAL AND STRATEGY-BUILDING SESSION TO TRAIN AND EMPOWER BREAST CANCER SURVIVORS AND OTHER ADVOCATES BY PROVIDING INFORMATION AND BACKGROUND ABOUT BREAST CANCER AS WELL AS THE TOOLS AND TACTICS NECESSARY TO TAKE A LEADERSHIP ROLE IN BREAST CANCER ADVOCACY.PROJECT LEAD, NBCC'S INNOVATIVE SCIENCE TRAINING COURSE, IS DESIGNED TO HELP BREAST CANCER ACTIVISTS INFLUENCE RESEARCH AND PUBLIC POLICY. AN INTENSIVE TWO-TO-SIX-DAY PROGRAM, PROJECT LEAD PREPARES ADVOCATES FOR PARTICIPATION IN THE WIDE RANGE OF FORUMS WHERE BREAST CANCER RESEARCH DECISIONS ARE MADE. PROJECT LEAD INCLUDES:- PROJECT LEAD INSTITUTE: ANNUAL INTENSIVE SIX-DAY COURSE IN CORE SCIENCE TRAINING FOR ADVOCATE LEADERS TO LEARN THE LANGUAGE AND CONCEPTS OF SCIENCE WITH A FOCUS ON THE BIOLOGY OF BREAST CANCER, GENETICS, EPIDEMIOLOGY, RESEARCH DESIGN, AND ADVOCACY.- ADVANCED PROJECT LEAD: ONGOING EDUCATIONAL AND TRAINING SESSIONS FOR ADVOCATES WHO EXCEL IN SCIENCE AND HAVE SUCCESSFULLY COMPLETED PROJECT LEAD FOCUSING ON ENHANCING CRITICAL THINKING AND RESEARCH SKILLS.- CONTINUING EDUCATION FOR PROJECT LEAD GRADUATES: CONTINUED SCIENTIFIC EDUCATION AND RESEARCH INVOLVEMENT, INCLUDING LEADGRADS ONLINE RESOURCES, ADVANCED TOPICS SESSIONS AT VARIOUS SCIENTIFIC MEETINGS, AND LEADCASTS - ONLINE WEBINARS WITH WELL-KNOWN RESEARCHERS.- ONLINE CENTER FOR ADVOCACY TRAINING: NBCC'S ESTEEMED TRAINING EXPERIENCES BROUGHT DIRECTLY TO ADVOCATES IN A CONVENIENT AND UNDERSTANDABLE DIGITAL FORMAT.- TEAM LEADER TRAINING: PREPARES GRASSROOTS LEADERS TO UNDERSTAND THE LEGISLATIVE PROCESS AND TO FORWARD NBCC'S ANNUAL PUBLIC POLICY AGENDA.
CATALYTIC RESEARCH PROJECTS AND COLLABORATIONS - NBCC'S ARTEMIS PROJECT IS CENTERED AROUND STRATEGIC SUMMITS, CATALYTIC WORKSHOPS, AND COLLABORATIVE EFFORTS WITH A MULTI- DISCIPLINARY AND DIVERSE...
CATALYTIC RESEARCH PROJECTS AND COLLABORATIONS - NBCC'S ARTEMIS PROJECT IS CENTERED AROUND STRATEGIC SUMMITS, CATALYTIC WORKSHOPS, AND COLLABORATIVE EFFORTS WITH A MULTI- DISCIPLINARY AND DIVERSE GROUP OF STAKEHOLDERS. THIS ADVOCATE-LED, INNOVATIVE APPROACH ALLOWS SCIENTISTS, INDUSTRY REPRESENTATIVES, AND REGULATORS TO WORK COLLABORATIVELY WITH ADVOCATES TO DEVELOP AND IMPLEMENT STRATEGIC RESEARCH PLANS THAT COULD HAVE A SIGNIFICANT IMPACT ON PRIMARY PREVENTION AND SAVING LIVES. PROJECTS INCLUDE:- ARTEMIS PROJECT FOR A PREVENTIVE BREAST CANCER VACCINE: A STRATEGIC PLAN FOR THE DEVELOPMENT OF A PREVENTIVE IN BREAST CANCER.- ARTEMIS PROJECT ON THE PREVENTIVE OF METASTASIS: DETERMINING THE PROCESS BY WHICH BREAST CANCER SPREADS AND BECOMES LETHAL, AND HOW TO INTERVENE TO STOP IT. - SEED GRANTS FOR RESEARCH: NBCC HAS AWARDED SEED GRANTS TO ALLOW SCIENTISTS TO BEGIN THE RESEARCH REQUIRED IN KEY AREAS IDENTIFIED IN THE COLLABORATIVE RESEARCH PLANS.CLINICAL TRIALS INITIATIVE - NBCC WORKS WITH INDUSTRY AND THE RESEARCH COMMUNITY ON CLINICAL TRIALS THAT MEET THE CRITERIA OF NBCC'S CLINICAL TRIAL PROJECT. WE INVOLVE BREAST CANCER ACTIVISTS IN ALL ASPECTS OF CLINICAL TRIAL DESIGN, IMPLEMENTATION, AND OVERSIGHT. WE WORK TO IMPROVE ACCESS TO QUALITY CLINICAL TRIALS AND, THUS, TREATMENT AND CARE FOR WOMEN WITH BREAST CANCER AND STRATEGIES FOR THOSE AT RISK.
PUBLIC POLICY - PUBLIC POLICY PLAYS A SIGNIFICANT ROLE IN ALL ASPECTS OF BREAST CANCER. NBCC FOCUSES ITS PUBLIC POLICY ADVOCACY ON PRIORITIES THAT WILL HAVE A MAJOR IMPACT ON ENDING BREAST CANCER...
PUBLIC POLICY - PUBLIC POLICY PLAYS A SIGNIFICANT ROLE IN ALL ASPECTS OF BREAST CANCER. NBCC FOCUSES ITS PUBLIC POLICY ADVOCACY ON PRIORITIES THAT WILL HAVE A MAJOR IMPACT ON ENDING BREAST CANCER, INCLUDING THOSE THAT WILL INCREASE FUNDING FOR MEANINGFUL BREAST CANCER RESEARCH, PROVIDE ACCESS TO HIGH-QUALITY HEALTH CARE AND CLINICAL TRIALS, AND EXPAND THE INFLUENCE OF BREAST CANCER ADVOCATES EVERYWHERE BREAST CANCER DECISIONS ARE MADE.NBCC HOSTS A SERIES OF CONGRESSIONAL FORUMS ON CAPITOL HILL DESIGNED TO EDUCATE POLICYMAKERS ON ISSUES VITAL TO THE BREAST CANCER COMMUNITY. NBCC PROVIDES MEMBERS OF CONGRESS AND THEIR STAFF UP-TO-DATE INFORMATION ABOUT BREAST CANCER AND REPORTS ON RESEARCH DISCOVERIES THAT AFFECT POLICY AND APPROPRIATIONS. NBCC LEADERSHIP OFTEN TESTIFIES BEFORE CONGRESSIONAL COMMITTEES ON SUBSTANTIVE BREAST CANCER ISSUES.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $4,391,769 | $4,538,715 | 0.0% |
| Expenses | $4,055,847 | $3,461,528 | +0.2% |
| Net Income | $335,922 | $1,077,187 | -0.7% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| FRANCES VISCO | PRESIDENT | 46.00 |
Officer
Director
|
$221,154 | $23,700 | $273,700 |
| ALEC CALL | CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| LINDA ROTHWEILER | VICE CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| CHRISTINE NORTON | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| IRA HILLMAN | TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| SHERRY GOLDMAN | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| JUDI HIRSHFIELD-BARTEK | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| DENNIS SLAMON | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| DOUGLAS WALL | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| LIANE LINDNER | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| BRYAN JOHNS | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| ANN YAHNER | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| MICHELE RAKOFF | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| BETH EMERY | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| TODD NICKEY | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| MARA WALKER | CHIEF OPERATING OFFICER | 38.00 |
Officer
|
$160,980 | $16,574 | $186,027 |
| MICHELLE TREGEAR | CHIEF PROGRAMS OFFICER | 39.00 |
Highest
|
$172,586 | $6,993 | $184,004 |
| MELANIE WYNE | CHIEF POLICY OFFICER | 32.00 |
Highest
|
$146,200 | $16,417 | $199,167 |
| MARY DULANEY | CHIEF ADVANCEMENT OFFICER | 38.00 |
Highest
|
$162,183 | $16,384 | $187,103 |
| ELIZABETH DELLSY | ARTEMIS PROJECT DIRECTOR | 40.00 |
Highest
|
$149,565 | $15,419 | $164,984 |
| MARGARET BUSH | DIRECTOR, GRASSROOTS ENGAGEMENT | 37.00 |
Highest
|
$110,936 | $5,623 | $125,554 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $4,391,769 | $4,055,847 | $6,725,511 | $335,922 |
| 2022 | $4,538,715 | $3,461,528 | $5,965,372 | $1,077,187 |
| 2021 | $4,285,005 | $2,743,843 | $4,829,949 | $1,541,162 |
| 2020 | $4,069,817 | $2,814,538 | $3,352,187 | $1,255,279 |
| 2019 | $3,497,608 | $3,213,764 | $2,223,139 | $283,844 |
| 2018 | $2,908,285 | $3,248,824 | $2,061,326 | $-340,539 |
Compare NATIONAL BREAST CANCER COALITION FUND with other nonprofits in District of Columbia and across the country.